ALLMedicine™ Bullous Pemphigoid Center
Research & Reviews 1,601 results
https://doi.org/10.1016/j.jid.2021.01.014
The Journal of Investigative Dermatology; Schilf P, Schmitz M et. al.
Feb 20th, 2021 - Bullous pemphigoid-like epidermolysis bullosa acquisita (EBA) is an autoantibody-driven, granulocyte-mediated skin disease. The role of cellular metabolism and its potential as therapeutic target in EBA are unknown. We investigated the effect of 2...
https://doi.org/10.1016/j.cpcardiol.2021.100799
Current Problems in Cardiology; Bulger DA, Minhas S et. al.
Feb 19th, 2021 - Chronic systemic skin disease and cardiovascular disease are multisystem disorders which have been associated with each other for centuries. Recent research has strengthened this association, particularly in systemic inflammatory disease. Here we ...
https://doi.org/10.1111/bjd.19830
The British Journal of Dermatology; Blome C, Klein TM
Feb 18th, 2021 - Classifying the severity of bullous pemphigoid disease.|2021|Blome C,Klein TM,|
https://doi.org/10.1111/1346-8138.15816
The Journal of Dermatology; Ujiie I, Iwata H et. al.
Feb 18th, 2021 - Bullous pemphigoid (BP) varies in severity and stratified treatments are needed. However, there are no definitive standards for choosing appropriate treatments. To elucidate the factors involved in choosing treatments and the clinical outcomes of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879621
BMC Endocrine Disorders; Lambadiari V, Kountouri A et. al.
Feb 12th, 2021 - Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid. The objective of our study was to prospectively e...
Guidelines 2 results
https://doi.org/10.1111/bjd.13717
The British Journal of Dermatology; Feliciani C, Joly P et. al.
Apr 1st, 2015 - Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affe...
https://doi.org/10.1111/bjd.12072
The British Journal of Dermatology; Venning VA, Taghipour K et. al.
Nov 5th, 2012 - British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012.|2012|Venning VA,Taghipour K,Mohd Mustapa MF,Highet AS,Kirtschig G,|therapeutic use,therapeutic use,therapeutic use,therapeutic use,therapeutic use,dia...
Clinicaltrials.gov 1,631 results
https://doi.org/10.1016/j.jid.2021.01.014
The Journal of Investigative Dermatology; Schilf P, Schmitz M et. al.
Feb 20th, 2021 - Bullous pemphigoid-like epidermolysis bullosa acquisita (EBA) is an autoantibody-driven, granulocyte-mediated skin disease. The role of cellular metabolism and its potential as therapeutic target in EBA are unknown. We investigated the effect of 2...
https://doi.org/10.1016/j.cpcardiol.2021.100799
Current Problems in Cardiology; Bulger DA, Minhas S et. al.
Feb 19th, 2021 - Chronic systemic skin disease and cardiovascular disease are multisystem disorders which have been associated with each other for centuries. Recent research has strengthened this association, particularly in systemic inflammatory disease. Here we ...
https://doi.org/10.1111/bjd.19830
The British Journal of Dermatology; Blome C, Klein TM
Feb 18th, 2021 - Classifying the severity of bullous pemphigoid disease.|2021|Blome C,Klein TM,|
https://doi.org/10.1111/1346-8138.15816
The Journal of Dermatology; Ujiie I, Iwata H et. al.
Feb 18th, 2021 - Bullous pemphigoid (BP) varies in severity and stratified treatments are needed. However, there are no definitive standards for choosing appropriate treatments. To elucidate the factors involved in choosing treatments and the clinical outcomes of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879621
BMC Endocrine Disorders; Lambadiari V, Kountouri A et. al.
Feb 12th, 2021 - Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid. The objective of our study was to prospectively e...
News 63 results
https://www.mdedge.com/dermatology/article/216651/dermatopathology/distinct-violaceous-plaques-conjunction-blisters?channel=204
Radhika Grandhi, MD, MPH, Christopher G. Bazewicz, MD et. al.
Feb 4th, 2020 - The Diagnosis: Lichen Planus Pemphigoides Lichen planus pemphigoides (LPP) is a rare autoimmune subepithelial blistering disorder with clinical, pathologic, and immunologic features of lichen planus (LP) and bullous pemphigoid (BP). 1 It mainly ari.
https://www.medscape.com/viewarticle/922005
Dec 19th, 2019 - What is bullous pemphigoid? Bullous pemphigoid is an autoimmune skin disease that causes the skin to form bullae or blisters. This video overview covers key aspects of the causes, symptoms, diagnosis, pathology, and treatment of bullous pemphigoid...
https://www.mdedge.com/dermatology/article/206392/aesthetic-dermatology/nicotinamide-containing-products-gaining-interest?channel=39313
Ted Bosworth
Aug 13th, 2019 - NEW YORK – More patients are inquiring about the antiaging claims made for nicotinamide products, according to Christine DeWitt MD, of the department of dermatology, Georgetown University, Washington. She encouraged attendees at the American Acade.
https://www.mdedge.com/dermatology/article/202797/autoimmune-diseases/bullous-systemic-lupus-erythematosus-successfully/page/0/1?channel=45
Jun 12th, 2019 - Comment Diagnosis of BSLE Bullous systemic lupus erythematosus is a rare cutaneous complication of SLE. It typically affects young black women in the second to fourth decades of life.
https://reference.medscape.com/viewarticle/865301_3
Apr 2nd, 2019 - Which of the following is the most likely diagnosis? Your Peers Chose: Bullous pemphigoid 0% Herpes zoster (shingles) 0% Pemphigus vulgaris 0% Fixed drug eruption 0% Bullous impetigo 0% Discussion The patient in this case exhibited many factors su...
